Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

138 7 Immunosuppresive Factors in Cancer
factor and transforming growth factorsb1,
-b2 and -b3 inhibit induction of
macrophage nitrogen oxide synthesis
by IFN-g. J. Immunol. 145: 940.
33 Alleva, D. G., C. J. Burger and
K. D. Elgert. 1994. Tumor-induced regulation
of suppressor macrophage nitric
oxide and TNF-a production. Role
of tumor-derived IL-10, TGF-b and prostaglandin
E 2. J. Immunol. 153: 1674.
34 Maeda, H., S. Tsuru and A. Shiraishi.
1994. Improvement of macrophage dysfunction
by administration of antitransforming
growth factor-b antibody
in EL4-bearing hosts. Jpn J. Cancer Res.
85: 1137.
35 Jun, C. D., B. M. Choi, S. U. Kim,
S. Y. Lee, H. M. Kim and H. T. Chung.
1995. Down-regulation of transforming
growth factor-b gene expression by antisense
oligodeoxynucleotides increases
recombinant interferon-g-induced nitric
oxide synthesis in murine peritoneal
macrophages. Immunology 85: 114.
36 Smyth, M. J., S. L. Strobl, H. A. Young,
J. R. Ortaldo and A. C. Ochoa. 1991.
Regulation of lymphokine-activated
killer activity and pore-forming protein
gene expression in human peripheral
blood CD8 + T lymphocytes. Inhibition
by transforming growth factor-b. J. Immunol.
146: 3289.
37 Lee, H. M. and S. Rich. 1993. Differential
activation of CD8 + T cells by transforming
growth factor-b1. J. Immunol.
151: 668.
38 Mule, J. J., S. L. Schwarz, A. B. Roberts,
M. B. Sporn and S. A. Rosenberg.
1988. Transforming growth factor-b
inhibits the in vitro generation of
lymphokine-activated killer cells and cytotoxic
T cells. Cancer Immunol. Immunother.
26: 95.
39 Espevik, T., I. S. Figari, G. E. Ranges
and M. A. Palladino, Jr. 1988. Transforming
growth factor-b1 (TGF-b1) and
recombinant human tumor necrosis
factor-a reciprocally regulate the generation
of lymphokine-activated killer
cell activity. Comparison between natural
porcine platelet-derived TGF-b1
and TGF-b2 and recombinant human
TGF-b1. J. Immunol. 140: 2312.
40 Espevik, T., A. Waage, A. Faxvaag and
M. R. Shalaby. 1990. Regulation of interleukin-2
and interleukin-6 production
from T-cells: involvement of interleukin-1b
and transforming growth factor-b.
Cell. Immunol. 126: 47.
41 Fargeas, C., C. Y. Wu, T. Nakajima,
D. Cox, T. Nutman and G. Delespesse.
1992. Differential effect of transforming
growth factor b on the synthesis of
T h1- and T h2-like lymphokines by human
T lymphocytes. Eur. J. Immunol.
22: 2173.
42 Ludviksson, B. R., D. Seegers,
A. S. Resnick and W. Strober. 2000.
The effect of TGF-b1 on immune responses
of naive versus memory CD4 +
T h1/T h2 T cells. Eur. J. Immunol. 30:
2101.
43 Kehrl, J. H., L. M. Wakefield,
A. B. Roberts, S. Jakowlew, M. Alvarez-Mon,
R. Derynck, M. B. Sporn
and A. S. Fauci. 1986. Production of
transforming growth factor b by human
T lymphocytes and its potential role in
the regulation of T cell growth. J. Exp.
Med. 163: 1037.
44 Inge, T. H., K. M. McCoy, B. M. Susskind,
S. K. Barrett, G. Zhao and
H. D. Bear. 1992. Immunomodulatory
effects of transforming growth factor-b
on T lymphocytes. Induction of CD8 expression
in the CTLL-2 cell line and in
normal thymocytes. J. Immunol. 148:
3847.
45 Ebert, E. C. 1999. Inhibitory effects of
transforming growth factor-b (TGF-b)
on certain functions of intraepithelial
lymphocytes. Clin. Exp. Immunol. 115:
415.
46 Cerwenka, A., D. Bevec, O. Majdic,
W. Knapp and W. Holter. 1994. TGFb
1 is a potent inducer of human effector
T cells. J. Immunol. 153: 4367.
47 Kasid, A., G. I. Bell and E. P. Director.
1988. Effects of transforming
growth factor-b on human lymphokineactivated
killer cell precursors. Autocrine
inhibition of cellular proliferation
and differentiation to immune killer
cells. J. Immunol. 141: 690.
48 Ahuja, S. S., F. Paliogianni, H.Yamada,
J. E. Balow and D. T. Boumpas.
1993. Effect of transforming growth fac-